DRUG · Mapped RxNorm record
Sitagliptin
Normalized identity: sitagliptinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
NCT00501657
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffects of Sitagliptin on Gastric Emptying in Healthy Subjects
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Gastroparesisverified · MONDO: gastroparesis
Diabetes Mellitusverified · MONDO: diabetes mellitus
Interventions
SitagliptinDRUG · verified · RxNorm: sitagliptin
PlaceboDRUG
Sponsors & collaborators
Royal Adelaide Hospitallead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00501657 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.